Nominations for the Broermann Medical Innovation Award 2026 now open

With a million euros, it is one of the world’s most highly endowed awards for medical research

HAMBURG, GERMANY – Newsaktuell – 5 September 2025 – The nomination period for the Broermann Medical Innovation Award 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made pioneering contributions in medicine, biotechnology, or related fields may be nominated. The nomination portal will remain open until March 1, 2026.

The Broermann Medical Innovation Award recognizes scientific breakthroughs with high innovation potential for clinical application. The focus is on research results that have a long-lasting impact on the lives and health of millions of people worldwide. The announcement of the award recipient and the second official Broermann Medical Innovation Award ceremony will take place in autumn 2026.

Debut of the Broermann Medical Innovation Award This Year

The award will be presented for the first time this year. The jury will announce the inaugural recipient of the Broermann Medical Innovation Award on September 18, 2025. The official award ceremony, hosted by the Minister-President of Hesse, Boris Rhein, will take place on November 14, 2025, at the Hessian State Chancellery in Wiesbaden.

Hashtag: #BroermannMedicalInnovationAward

The issuer is solely responsible for the content of this announcement.

About the Award

The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, founder of the Asklepios Kliniken Group. The award is endowed by Broermann gemeinnützige GmbH and organized through the University Hospital Gießen and Marburg (UKGM). The award is intended to recognize groundbreaking medical discoveries and highlight those whose research is making real progress in the prevention or treatment of disease. The aim is to reflect the award founder’s firm conviction that, although scientific excellence in medicine is always an international team effort, the impact of networks is limited without the genius of individual researchers. The Broermann Medical Innovation Award is intended to recognize and support these key figures and drivers of medical innovation worldwide.

Further information about the award, nomination criteria, and selection process can be found on the award website.

Contact:

Broermann Medical Innovation Award
Contact: Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org

Asklepios Kliniken
Konzernbereich Unternehmenskommunikation & Marketing
Tel.: +49 (0) 40 / 18 18-82 66 36
E-Mail: presse@asklepios.com

24-hour press office hotline:+49 (0) 40 / 1818-82 8888

Visit Asklepios on the Internet and Social Media:
www.asklepios.com
www.asklepios.com/gesundheitsmagazin
http://www.youtube.com/asklepioskliniken
de.linkedin.com/company/asklepios
www.instagram.com/asklepioskliniken/
www.facebook.com/asklepioskliniken

Adlena Wong

Recent Posts

Crisis Management Centre Announces Global Release Of Founder’s Maiden Book on Reputational Security

NEW YORK, US / KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 27 December 2025…

2 days ago

Can Gio Awakens as Ho Chi Minh City’s Next Growth Frontier

After decades of quiet, Can Gio is awakening on Vietnam’s southern coast, as fresh investment…

2 days ago

Z.ai Open-Sources GLM-4.7, a New Generation Large Language Model Built for Real Development Workflows

SINGAPORE - Media OutReach Newswire - 26 December 2025 - Z.ai has released GLM-4.7, the…

3 days ago

A Holiday Christmas Magic: Coca-Cola Bridges Miles by Bringing “Sound of Home” to Overseas Filipino Workers in Australia

In partnership with SBS, Australia’s multicultural and multilingual public broadcaster, Coca-Cola delivered a 24-hour Christmas…

3 days ago

Apical Strengthens Women’s Health to Support Stunting Prevention in Cilincing, North Jakarta

SINGAPORE - Media OutReach Newswire - 26 December 2025 – Apical continues to reinforce its…

3 days ago